MedTrace Logo

Luma Light System Proof of Concept Study in Subjects With Mild to Moderate Psoriasis

NCT02447068 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2015-05-20

No results posted yet for this study

Summary

This is a proof of concept, investigator blinded study to evaluate the efficacy and safety of a novel combination of a home narrow band ultraviolet B (NBUVB) lamp with an occlusive dressing in adult subjects with mild to moderate psoriasis vulgaris. Four interpatient arms will be used to compare the efficacy of combination of NBUVB with an occlusive dressing to the light alone and to dressing alone and no treatment. Ten patients will be enrolled in this 6 weeks study.

Conditions

Interventions

DEVICE

Luma Light System

The Luma Light System combines a NBUVB light with an occlusive dressing.

DEVICE

Luma Light

NBUVB light

DEVICE

Occlusive Dressing

Off-the-shelf occlusive dressing

Sponsors & Collaborators

  • Illumicure Inc

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02447068 on ClinicalTrials.gov